COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR PATIENTS WITH CHRONIC HCV IN THE NETHERLANDS

被引：1
|
作者：
Gaultney, J. [1 ]
de Knegt, R. J. [2 ]
Fassler, P. [3 ]
Visser, S. [3 ]
Johnson, S. [4 ]
机构：
[1] Mapi Grp, Houten, Netherlands
[2] Erasmus MC, Rotterdam, Netherlands
[3] AbbVie BV, Hoofddorp, Netherlands
[4] Medicus Econ LLC, Milton, MA USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1504
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN71
引用
收藏
页码：A588 / A588
页数：1
相关论文
共 50 条
  • [41] Treatment uptake and real world effectiveness of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir/dasabuvir among HCV-infected persons with chronic kidney disease
    Alkadi, M. M.
    Ren, Y.
    Puenpatom, A.
    Kumar, R.
    Arduino, J. M.
    Abou-Samra, A-B
    Butt, A. A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S724 - S725
  • [42] Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program
    Andreoni, Massimo
    Teti, Elisabetta
    Antinori, Andrea
    Milazzoi, Laura
    Sollima, Savatore
    Rizzardini, Giuliano
    Di Biagio, Antonio
    Saracino, Annalisa
    Bruno, Raffaele
    Borghi, Vanni
    De Luca, Andrea
    Cattelan, Annamaria
    Hasson, Hamid
    Taliani, Gloria
    Monforte, Antonella D'Arminio
    Mastroianni, Claudio Maria
    Di Perri, Giovanni
    Bigoni, Sara
    Puoti, Massimo
    Spinetti, Angiola
    Gori, Andrea
    Boffa, Nicola
    Cacopardo, Bruno
    Giacometti, Andrea
    Parruti, Giustino
    Vullo, Vincenzo
    Chirianni, Antonio
    Pennica, Alfredo
    Pasquazzi, Caterina
    Segala, Daniela
    Sarmati, Loredana
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (05) : 680 - 683
  • [43] SAFETY & EFFICACY OF COMBINATION THERAPY WITH OMBITASVIR, PARITAPREVIR & RITONAVIR PLUS DASABUVIR IN HCV-INFECTED PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING HEMODIALYSIS
    Lazarou, Dimitrios
    Xynotroulas, Ioannis
    Provatopoulou, Simella
    Vogiatzi, Apostolia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [44] Exposure-Efficacy Analyses of Ombitasvir, Paritaprevir/Ritonavir with Dasabuvir ± Ribavirin in HCV Genotype 1-Infected Patients
    Khatri, Amit
    Mensing, Sven
    Podsadecki, Thomas
    Awni, Walid
    Menon, Rajeev
    Dutta, Sandeep
    CLINICAL DRUG INVESTIGATION, 2016, 36 (08) : 625 - 635
  • [45] Ledipasvir/sofosbuvir; ombitasvir/paritaprevir/ritonavir/dasabuvir sodium monohydrate; and peramivir
    Hussar, Daniel A.
    Kavelak, Haley L.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2015, 55 (02) : 216 - 222
  • [46] Severe Hepatotoxicity of Ritonavir, Ombitasvir, Paritaprevir, and Dasabuvir in a Kidney Transplant Recipient
    Bukal, Nikolina
    Furic-Cunko, Vesna
    Juric, Ivana
    Katalinic, Lea
    Dedo, Antonia
    Basic-Jukic, Nikolina
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2019, 30 (05) : 1184 - 1186
  • [47] TREATMENT UPTAKE AND REAL WORLD EFFECTIVENESS OF SOFOSBUVIR/LEDIPASVIR AND PARITAPREVIR/RITONAVIR/OMBITASVIR/DASABUVIR AMONG HCV-INFECTED PERSONS WITH CHRONIC KIDNEY DISEASE
    Alkadi, Mohamad
    Ren, Yanjie
    Puenpatom, Amy
    Kumar, Ritesh
    Arduino, Jean Marie
    Abou-Samra, Abdul-Badi
    Butt, Adeel
    GASTROENTEROLOGY, 2017, 152 (05) : S1100 - S1101
  • [48] Safety assessment in Child A cirrhotic patients treated with Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin
    Manea, E. D.
    Stefan, I
    Olariu, C.
    Calina, O. C.
    Jipa, R. E.
    Hristea, A.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (01) : 9 - 13
  • [49] Virological response to ombitasvir/paritaprevir/ritonavir plus dasabuvir plus ribavirin in 150 patients with mixed cryoglobulinaemia and HCV infection
    Gheorghe, Liana
    Iacob, Speranta
    Iacob, Razvan
    Gheorghe, Cristian
    HEPATOLOGY, 2016, 64 : 956A - 956A
  • [50] Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir plus dasabuvir in patients with chronic kidney disease: an ERCHIVES study
    Butt, A. A.
    Ren, Y.
    Puenpatom, A.
    Arduino, J. M.
    Kumar, R.
    Abou-Samra, A-B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 35 - 43
12345